Back to MBX

CITADEL ADVISORS LLC → MBX

CITADEL ADVISORS LLC MBX Position History

MBX Biosciences, Inc. • Healthcare

Quarters held
8
Latest value
$210K
Q2 2026
Peak value
$25.8M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$25.8M
Q1 2026$296K
Q1 2026$2M
Q1 2026$755K
Q2 2026$1.2M
Q2 2026$210K
Q2 2026$1.2M
Q2 2026$210K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$210K3.8K——
Q2 2026$1.2M22.4K——
Q2 2026$210K3.8K——
Q2 2026$1.2M22.4K——
Q1 2026$755K25.3K——
Q1 2026$2M67.7K——
Q1 2026$296K9.9K——
Q1 2026$25.8M865.1K——

Other funds holding MBX

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
SPY

SPDR S&P 500 ETF TR

$3B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
NVDA

NVIDIA CORPORATION

$2.1B
SPY

SPDR S&P 500 ETF TR

$2.1B
NVDA

NVIDIA CORPORATION

$2.1B